chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The pt developed abdominal pain described as "sudden onset" pain which lasts for one hour and cries during the period of pain. This report was received on 10/19/99, the pt's symptoms persisted. He is being treated wit Zantac, with temporary relief. He is being evaluated for gastroesophageal reflux.
Numbness, tingling, pressure in head, burning mouth syndrome, heavy legs, back pain. Diagnosed with Myelitis.
A 3rd dose of Shingrix was given on 06/06/2022. The patient already received 2 doses of Shingrix at the other healthcare facilities. These information was found on system when the patient came in on 08/06/2022. Unknown adverse event(s).
Rare Diagnosis of Ramsay Hunt Syndrome (Shingles in the inner & outer of the left ear & throat) aka Herpes Zoster Oticus.   Bedridden, Extreme fatigue,  weight loss, weakness, body aches, pain in throat & ear, lymphodema, severe virtigo, tonsillitis, and permanent  hearing lose.
Red rashs, burning itching and mild pain at injection site and seperate area on left upper arm. First Started on April 8th.
itchy fingers and itchy under the finger nails; ache in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (ache in the arm) and PRURITUS (itchy fingers and itchy under the finger nails) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination.     Concurrent medical conditions included Celiac disease and Myasthenia gravis.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (ache in the arm). On 25-Mar-2021, the patient experienced PRURITUS (itchy fingers and itchy under the finger nails). On 24-Mar-2021, PAIN IN EXTREMITY (ache in the arm) had resolved. On 25-Mar-2021, PRURITUS (itchy fingers and itchy under the finger nails) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided by reporter. No concomitant medications were provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Form was attached and outcome of events updated.Patient provided email address.
Day after injection: Swollen arm around injection site. Day two after injection: After swelling decreased I had swelling under my arm with a knot the size of a golf ball. Very sore and tender to touch.
Received imm 8-16-12 started with rash 8-18-12 taken to ER 8-19-12 had oral lesions & thick rash head to toe with itchy no temp; her loss of appetite. Using BENADRYL liquid of 6-8 hours prn using TYLENOL cream prn.
4 hrs after injection experienced joint pain in wrists and hands, treated with Extra Strength Acetaminophen  10 hrs after injection experienced fever &  chills, body aches, headache and continued joint pain in wrists and hands;  treated with Extra Strength Acetaminophen throughout night 21 - 28 hrs after injection continued to have headache;  treated with Extra Strength Acetaminophen
having a splitting headache; tenderness at the injection site; This is a spontaneous report from a contactable consumer, the patient. This 73-year-old female patient reported that she received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route in Mar2021 (at the age of 73-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received her first vaccine dose yesterday (estimated as Mar2021) around 10:15 AM and at 6 PM she began having a splitting headache. The patient also reported tenderness at the injection site. The clinical outcomes of splitting headache and tenderness at the injection site were unknown.  Follow-up attempts are completed. No further information is expected. Information about lot number cannot be obtained.
Patient came and told me that she had her flu shot about 3 weeks ago and she started to itch on her legs, chest, and arms about 2 days after the shot. She stated that this is her first time having a reaction to a flu shot, being that she gets one every year. She also stated that she is positive that it was the flu shot that caused it and not any of her medications.
Shortly after receiving the second dose of the Pfizer vaccine, I noticed my teeth had become sensitive to hot cold liquid. I had seen the dentist roughly 2 months prior for a regularly scheduled tooth cleaning, and from what I recall, there weren't any signs that would indicate poor oral health. The following weekday after receiving the second dose, I made a dentist appointment out of fear that I would need a root canal or other serious procedure. They took an x-ray and found nothing, put some de-sensitizing gel on the area that bothered me the most, and strongly suggested I get my wisdom teeth removed. It very likely could be a complete coincidence, unrelated to the vaccine, but I'm not a doctor. The sensitivity persists even after wisdom tooth removal, albeit less intense - the reduction in sensitivity could also be due to switching to a tooth-sensitivity toothpaste.at the dentist's recommendation.
began feeling sick 19SEP, 10PM & was ill 19SEP & 20SEp still not feeling well, c/o chills, n/v, hurting across back, pain in rt side, feeling pressure under ribs on rt side;states believes liver may be enlarged;c/o feeling clammy & warm
Event occurred after 2nd dose. Patient was diagnosed with COVID. Tylenol, Remdesivir IN-patient
Have never seen it cause shingles before; Initial local redness over his upper arm; Muscle pain in the upper arm / forearm; Rash over his forearm; This case was reported by a physician and described the occurrence of shingles in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th November 2020, the patient received the 1st dose of Shingrix. In November 2020, less than a week after receiving Shingrix, the patient experienced shingles, erythema of extremities, myalgia upper extremities and rash. On an unknown date, the outcome of the shingles, erythema of extremities, myalgia upper extremities and rash were unknown.   It was unknown if the reporter considered the shingles, erythema of extremities, myalgia upper extremities and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had local redness over his upper arm.  Within a few days began experiencing muscle pain in the upper arm that moved into his forearm.  The patient then developed a rash over his forearm and shingles. The reporter asked was this a known side effect.
Increased redness, swelling, and pain around injection site.  Pt went to ER and was diagnosed with cellulitis.  Antibiotic was prescribed.
Erythema and induration 3-4cm in diameter also papulovesicular rash all over body each 1-2mm, induration felt warm.
I was later diagnosed with pericarditis and I had all the common symptoms for two months. Fast beating heart, and feelings of weirdness around the heart. I really didn't know what was happening. I wondered if I was going to die. After the tests, the doctor told me to sit tight and it would settle down. That's where I am at now, but I don't know if I should take the booster from Pfizer or perhaps go with J&J. This happened some time ago, and my cardiologist at the time suggested to take it easy.
After leaving clinic patient felt congestion, headache, body aches, cramping, continued next day went to ER given TORADOL and BENADRYL. Patient felt better and was discharged
This spontaneous report as received from a medical assistant refers to unknown number of patients of unknown age and gender. Since 17-JUN-2014, (in approximately 2014, exact date was not reported) unknown number of patients were inadvertently vaccinated with ROTATEQ oral (lot#, expiration date, dose not reported) that had been improperly stored (since unknown date). No concomitant medications were reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I got two doses of the Pfizer vaccine. First dose on 4/5/21 second on 4/26/21 Over the last several weeks I have starting the to have problems with taste. The mint tums I take for heartburn started to taste nasty. Then chocolate started tasting bad. I used to love good dark chocolate, now any chocolate is disgusting. Yesterday I had a frozen Coca Cola at McDonald?s. It had that same nasty taste as the tums and chocolate but much worse. Lemon scented cleaners smell like the bad covid taste. Toothpaste has the nasty taste and some candies taste that way also. It seems more and more things are starting to have this nasty taste and the effects keep getting worse.
Patient received covid booster shot (mfg unknown) 3 hours prior to arrival to ER.  Patient complains of severe chest pain and shortness of breath.  Pain is 9 out of 10.  Patient is pale and diaphoretic.  Patient goes to cath lab for percutaneous intervention for 100 % acute occlusion of the mid LAD.  Patient recovers in critical care unit.
The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022; 36 doses administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) in a 39-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination.     Patient had no known allergies.  Concurrent medical conditions included Gastritis. Concomitant products included OMEPRAZOLE and ASCORBIC ACID, FERROUS FUMARATE (VITRON C [ASCORBIC ACID;FERROUS FUMARATE]) for an unknown indication.    On 13-Apr-2022 at 3:16 PM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 13-Apr-2022 at 3:16 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   The vial was initially stored in the refrigerator on 25-Feb-2022. The vial did not undergo any temperature excursions. No treatment medication information was provided.
MA gave Kinrix for a 14 month which Kinrix is not recommened for this age. Patient should have received Pentacel.
Sharp pain-during elevation. Rash on abdominal area-pt took BENADRYL-5 day after 8-9 day it continue. Pt experiences pain on arm shot administer (11/7/14).
Redness/swelling/induration of right upper arm extending to lower arm onset 8/12/16. Circumferences: RUA 23.7cm RLA 20cm LUA 20cm LLA 17.5cm. tx BENADRYL, Ibuprofen every 6 hours starting 8/12.
A few days after I got my shot, I noticed unexplained bruises on my thighs around my knees and a very large bruise across my left thigh.  Today I feel numbness on the tip of my tongue. It started about an hour ago.
Patient received vaccine at 3:30 PM. Felt nauseous on the ride home. Vomited later that night. Felt better right after.
THERE WAS NO ADVERSE REACTION.  CHILD WAS INCORRECTLY GIVEN A DOSE OF MENACTRA.  AFTER SPEAKING WITH VACCINES FOR CHILDREN, THEY RECOMMENDED WE FILL OUT THIS FORM.
Splitting headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Splitting headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced HEADACHE (Splitting headache). At the time of the report, HEADACHE (Splitting headache) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not reported.  Treatment details included Aleve.
Headache, Sedation, Myalgia, Arthralgia, abd pain, injection site pain Narrative:
Patient began to feel effects from vaccine the evening after injection. Patient described chills, headache, body ache, weakness, nausea. As of 08/28 symptoms still present.
Redness itching inflammation at injection starting 1 day after vaccine and continuing  for 2 days
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's relevant medical history, concurrent conditions and concomitant medications were unknown. On 27-AUG-2018, the patient was vaccinated with an improperly stored dose of PROQUAD for prophylaxis, lot # R011215 and expiration date 15-OCT-2019 (reported as 15-MAR-2019) (dose, strength, and route of administration were unknown). No adverse effects were reported. The reporter stated that the vaccine was stored at a temperature of -14°C to -10°C for 30 minutes and -9°C to 8°C for 2 hours. Digital data logger was involved.
She had tdap immunization yesterday. At 1100 pm she developed onset of HA/dizziness/chills/ nauseated. She also reported to her mom some lower back pain and frequency. No dysuria. Temp normal. Today she feels better, slight HA, slight dizziness. Right arm has very slight swelling noted/tender to touch but no redness. She was restless and did not sleep well. She feels better today, but still slightly dizzy when she gets up quickly. She had tick bite a few weeks ago; no rash.  She has poor appetite; has not eaten today.
Rash to bilateral arms, trunk and chest, 3 hours, post vax. Pt was seen by MD, later that day and was given Rx for Zyrtec 10mg 1 qd X 30, Prednisone 40mg 1 qd X 5 days. Per doc 212746, patient is fairly certain she had 3 doses of HebB series in 1989. Facility has closed, no records available.
Vial initially stored on 01-Jun-2022 and then administered on 27-Jul-2022; administer the vaccine  from a vial that  was open on 1Jun2022 to  patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer the vaccine  from a vial that  was open on 1Jun2022 to  patient) and PRODUCT STORAGE ERROR (Vial initially stored on 01-Jun-2022 and then administered on 27-Jul-2022) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046L21A, 045C21A and 076C21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 29-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jul-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (administer the vaccine  from a vial that  was open on 1Jun2022 to  patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial initially stored on 01-Jun-2022 and then administered on 27-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer the vaccine  from a vial that  was open on 1Jun2022 to  patient) and PRODUCT STORAGE ERROR (Vial initially stored on 01-Jun-2022 and then administered on 27-Jul-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not tested positive for COVOD-19. No medical history reported relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Dose administered after 30-day Use By Date or after manufacturer date of expiry. No concomitant medication was reported. Date the vial was initially stored in the refrigerator on 1-Jun-2022. HCP administered the vaccine from a vial that was open on 1-Jun-2022 to 6 patients. The vial did not undergo any temperature excursions. No treatment information was reported.   This case was linked to MOD-2022-615628 (Patient Link).
Case completed primary vaccine series in February 2021, Then was hospitalized for Covid in February of 2022. Hospitalized at:  Hospital   * Febrile illness, acute Assessment & Plan -The patient reports fever as high as 105 on Monday. -other sxs are nasal congestion, diarrhea, sore throat, neck pain.  -LP negative for infection. -Routine infectious w/u negative.  - COVID-19 is the likely etiology with a persistently positive test and a cycle time of 34.2. He had no evidence of hypoxemia.  -Stool c diff negative -stool pathogen negative  -respiratory pathogen panel negative on admission    Significantly improved with reduced white count, resolving diarrhea on Rocephin, Flagyl, remdesivir   COVID-19 Assessment & Plan Was positive with a home test on 2/5 and he had URI symptoms and myalgias at that time that lasted approximately 5 days and resolved   On 2/21/2022 he developed fever to 105, sinus congestion, headache, neck stiffness and loose watery diarrhea. Covid on admission had a cycle time of 34   He was treated with IV remdesivir with resolution of his symptoms. Remdesivir will be discontinued at the time of discharge.
He was completely fine and ate no new foods in the 24hrs between the shot and the onset of symptoms. He took a nap and woke with an angry red and itchy rash over his outer thighs, hips, and buttocks. It spread to a patch on his left outer arm and his right cheek. The vaccination was administered (flu shot) in his left outer thigh. Daycare provider put calamine lotion on the rash, which helped, and his rash looked much better in a couple hours. He remained mostly clear of rash until 3:00pm the next day (9/26) when the exact same thing occurred again (down for nap, up with terrible rash). This time was given Benadryl and calamine lotion and the rash had calmed way down within two hours. I am typing this on 9/27/13 at 1:30pm and am waiting to hear if we have the problem again today. In an abundance of caution, I dressed him in light cotton clothes today (rather than jeans) and selected things that had not been washed in some time in case there was a detergent issue.
Spotting, bleeding; Cramping; Pain in arm; Hot; Strange feeling in my inner ear; Metal taste; Light-headed; Chills; Tired; Head pain, intermittent; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VAGINAL HAEMORRHAGE (Spotting, bleeding), MUSCLE SPASMS (Cramping), PAIN IN EXTREMITY (Pain in arm), FEELING HOT (Hot) and INNER EAR DISORDER (Strange feeling in my inner ear) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hormone replacement therapy.    On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VAGINAL HAEMORRHAGE (Spotting, bleeding), MUSCLE SPASMS (Cramping), PAIN IN EXTREMITY (Pain in arm), FEELING HOT (Hot), INNER EAR DISORDER (Strange feeling in my inner ear), DYSGEUSIA (Metal taste), DIZZINESS (Light-headed), CHILLS (Chills), FATIGUE (Tired) and HEADACHE (Head pain, intermittent). At the time of the report, VAGINAL HAEMORRHAGE (Spotting, bleeding), MUSCLE SPASMS (Cramping), PAIN IN EXTREMITY (Pain in arm), FEELING HOT (Hot), INNER EAR DISORDER (Strange feeling in my inner ear), DYSGEUSIA (Metal taste), DIZZINESS (Light-headed), CHILLS (Chills), FATIGUE (Tired) and HEADACHE (Head pain, intermittent) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound pelvis: (normal) normal.         No Concomitant medications were provided No treatment information provided.    This case was linked to MOD-2021-086998, MOD-2021-086998 (Patient Link).
Nausea and weakness for 2 weeks. Unable to eat, dry mouth.  Treated with zofran, remeron, promethazine.
Disruption of menstrual period: first period post-vaccine was late by nearly a week; This is a spontaneous report from a contactable other health professional (patient). A non-pregnant adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), intramuscular, administered in arm left on 22Feb2021 at 11:00 as unknown, single for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medication included spironolactone taken for an unspecified indication, start and stop date were not reported. The patient experienced disruption of menstrual period: first period post-vaccine was late by nearly a week, then the next three periods have come early by 7-20 days on 22Feb2021. There was no treatment received for the event. The outcome of the event was recovering.    Information about lot/batch number has been requested.
Approx 2 hrs after immunization, Pt felt dizzy and lightheaded.  Later that night, she experienced nausea, sweaty and clammy, and a fever of 101.2 degrees F.  After a good nights rest, she felt a lot better.  No further effects noted.
FEVER; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1085031, expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 09:00 am to left arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and the outcome of headache was not reported. This report was non-serious.
Dose of Tdap administered to client, but at least half of immunization leaked from hub between vaccine and needle due to needle not being secured tightly. Verified with Immunization Program, and recommended follow up dose of Tdap. Parent notified.  Administered following day 11/10/2022 with no adverse reactions noted.
Patient with complaints of dizziness.  Medics called to chair side for patient assessment. Patient legs elevated on chair. Assessment of vitals   B/P-77/35 HR-98 O2 Saturation-100%  Patient placed on stretcher with legs elevated above heart level by paramedics and drinking  Gatorade for hydration.  Vitals rechecked at 1705: B/P-100/58 HR-89 O2 Saturation-100%  Patient voiced feels better and transferred back into chair where she is stable. Denies any distress or symptoms of changes at this time.
Patient received ZOSTAVAX on 11-14-15. On 11-16-15 patient reported to pharmacy that her right upper arm was red and swollen. On 11-19-15 pharmacist called to check on her. Her arm is much better - swelling gone and redness improving.